相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors
Shuyan Dai et al.
CELLS (2019)
Future applications of FGF/FGFR inhibitors in cancer
Gaia Cristina Ghedini et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Milind Javle et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling
Katelyn N. Nelson et al.
Oncotarget (2018)
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
Xu Liang et al.
BREAST CANCER RESEARCH (2018)
FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling
C. Daly et al.
ONCOGENE (2017)
FGFR3-TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindle
Sourav Sarkar et al.
OPEN BIOLOGY (2017)
FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
Lukasz Turczyk et al.
NEOPLASIA (2017)
A Versatile Tumor Gene Deletion System Reveals a Crucial Role for FGFR1 in Breast Cancer Metastasis
Wei Wang et al.
NEOPLASIA (2017)
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma
H. R. Kim et al.
ANNALS OF ONCOLOGY (2017)
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
Teresa Helsten et al.
CLINICAL CANCER RESEARCH (2016)
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers
D. Fumagalli et al.
ANNALS OF ONCOLOGY (2016)
Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study
Lori M. van Roozendaal et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Efficacy and Safety of Dovitinib in Pretreated Patients With Advanced Squamous Non-Small Cell Lung Cancer With FGFR1 Amplification: A Single-Arm, Phase 2 Study
Sung Hee Lim et al.
CANCER (2016)
Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies
Timothy M. Shaver et al.
CANCER RESEARCH (2016)
Oncogenic Gene Fusion FGFR3-TACC3 Is Regulated by Tyrosine Phosphorylation
Katelyn N. Nelson et al.
MOLECULAR CANCER RESEARCH (2016)
Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer
Chee Leong Cheng et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Rationale for targeting fibroblast growth factor receptor signaling in breast cancer
Fabrice Andre et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
Anna Luisa Di Stefano et al.
CLINICAL CANCER RESEARCH (2015)
New treatment strategies for patients with triple-negative breast cancer
Cornelia Liedtke et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2015)
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors
Josep Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Extending the Limits of Quantitative Proteome Profiling with Data-Independent Acquisition and Application to Acetaminophen-Treated Three-Dimensional Liver Microtissues
Roland Bruderer et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling
Siru Zhou et al.
PLOS GENETICS (2015)
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Matthew D. Burstein et al.
CLINICAL CANCER RESEARCH (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
R. Dienstmann et al.
ANNALS OF ONCOLOGY (2014)
Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma
Li Yuan et al.
CANCER BIOLOGY & THERAPY (2014)
New Strategies for Triple-Negative Breast Cancer-Deciphering the Heterogeneity
Ingrid A. Mayer et al.
CLINICAL CANCER RESEARCH (2014)
Prognostic Value of FGFR Gene Amplification in Patients with Different Types of Cancer: A Systematic Review and Meta-Analysis
Jinjia Chang et al.
PLOS ONE (2014)
Oncogenic FGFR3 gene fusions in bladder cancer
Sarah V. Williams et al.
HUMAN MOLECULAR GENETICS (2013)
Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer
Hye Ryun Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
FGFR3 has tumor suppressor properties in cells with epithelial phenotype
Marie Lafitte et al.
MOLECULAR CANCER (2013)
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Yi-Mi Wu et al.
CANCER DISCOVERY (2013)
Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
A. Nigel Brooks et al.
CLINICAL CANCER RESEARCH (2012)
Increased Expression of Fibroblastic Growth Factor Receptor 2 Is Correlated With Poor Prognosis in Patients With Breast Cancer
Shanshan Sun et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
Devendra Singh et al.
SCIENCE (2012)
FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo
Rachel Sharpe et al.
CLINICAL CANCER RESEARCH (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Nicholas Turner et al.
CANCER RESEARCH (2010)
Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
Falko Hochgraefe et al.
CANCER RESEARCH (2010)
Roles of Fibroblast Growth Factor Receptors in Carcinogenesis
Ellen Margrethe Haugsten et al.
MOLECULAR CANCER RESEARCH (2010)
The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells
A. Roidl et al.
ONCOGENE (2010)
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
N. Turner et al.
ONCOGENE (2010)
Immunohistochemical Detection of Fibroblast Growth Factor Receptor 3 in Human Breast Cancer: Correlation with Clinicopathological/Molecular Parameters and Prognosis
Kazuko Kuroso et al.
PATHOBIOLOGY (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Triple-Negative Breast Cancer: Risk Factors to Potential Targets
Bryan P. Schneider et al.
CLINICAL CANCER RESEARCH (2008)
Triple negative tumours: a critical review
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
Somaia Elbauomy Elsheikh et al.
BREAST CANCER RESEARCH (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas
Jorge Sergio Reis-Filho et al.
CLINICAL CANCER RESEARCH (2006)
FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer
P Mhawrech-Fauceglia et al.
EJSO (2006)
分享论文
